<DOC>
	<DOCNO>NCT02546648</DOCNO>
	<brief_summary>A placebo-controlled , factorial trial assess impact rosuvastatin tranexamic acid ( TXA ) patient undergo noncardiac surgery risk perioperative cardiovascular event .</brief_summary>
	<brief_title>PeriOperative ISchemic Evaluation-3 Trial : A Pilot Study</brief_title>
	<detailed_description>The POISE-3 pilot randomize control trial 100 patient , risk , atherosclerotic disease undergo noncardiac surgery . Utilizing partial factorial design , POISE-3 pilot determine effect rosuvastatin versus placebo TXA versus placebo perioperative setting .</detailed_description>
	<mesh_term>Tranexamic Acid</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1. undergoing noncardiac surgery 2 . &gt; 45 year age 3. expect require least overnight hospital admission surgery ; AND 4. preoperative NTproBNP measurement &gt; 100 ng/mL ; OR 5. preoperative NTproBNP measurement available , patient must fulfill 1 follow 5 criterion : history coronary artery disease history peripheral vascular disease history stroke undergoing major vascular surgery 3 follow 9 risk criterion : undergoing major surgery history congestive heart failure history transient ischemic attack diabetic currently take oral hypoglycemic agent insulin age &gt; 70 year hypertension serum creatinine &gt; 175 umol/L ( &gt; 2.0 mg/dl ) history smoke within 2 year surgery undergo emergent/urgent surgery 1. plan use systemic Tranexamic Acid surgery 2. hypersensitivity know allergy TXA 3. creatinine clearance &lt; 30 mL/min ( MDRD ) 4. history seizure disorder 5. history venous thromboembolism 6. acute arterial thrombosis 7. preoperative measurement hemoglobin 8. subarachnoid hemorrhage within past 30 day 9. hematuria cause disease renal parenchyma 10. previously enrol POISE3 pilot trial 11. consent participate POISE3 pilot trial prior surgery Patients meeting follow criterion exclude Rosuvastatin/Placebo arm : 1. preoperative treatment statin non statin lipid lower drug ciclosporin 48 hour surgery 2. hypersensitivity know allergy Rosuvastatin 3. predispose factor myopathy rhabdomyolysis</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>